Brian James, DO
Interventional Pain Medicine · Austin, TXNPI 1376905570
Payments from drug & device makers
Across 38 payments — averaging $63.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$1K
- Medtronic$789
- SPR Therapeutics, Inc$203
- Saluda Medical Americas, Inc.$94
- MML US, Inc.$90
- Abbott$56
- plus $112 from 4 others
What the payments were for
- Travel & lodging$1,32955%
- Food & beverage$1,06645%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 19 | $1,051 |
| Medtronic | 9 | $789 |
| SPR Therapeutics, Inc | 3 | $203 |
| Saluda Medical Americas, Inc. | 1 | $94 |
| MML US, Inc. | 1 | $90 |
| Abbott | 1 | $56 |
| Globus Medical | 1 | $38 |
| Innovation Technologies Inc | 1 | $28 |
| Si-bone, Inc. | 1 | $26 |
| Averitas Pharma Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$712
- INTELLIS ADAPTIVESTIM$453
- INCEPTIV$141
How this compares
$2,395 in reported general payments places this provider in the 30th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DescovyEmtricitabine/Tenofov Alafenam | 442 | $899,542 |
| Emtricitabine-Tenofovir DisopEmtricitabine/Tenofovir (Tdf) | 429 | $95,305 |
| Oxycodone Hcl | 16 | $430 |
| Duloxetine Hcl | 18 | $266 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $251 |
| Doxycycline Hyclate | 32 | $245 |
| Gabapentin | 14 | $233 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Austin
- Genaro GutierrezAustin$1.3M
- Brannon FrankAustin$698K
- Anjuli DesaiAustin$82K
- Paul leAustin$27K
- Martin ThaiAustin$23K
- Clayton AdamsAustin$22K
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.2M
- Chad StephensSouthlake$1.1M
- Ioannis SkaribasHouston$979K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.